Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px

Person › Details

Claus Kremoser (Phenex Pharmaceuticals AG)

Kremoser, Claus (Phenex 201106 CEO)

	Organisation	Phenex Pharmaceuticals AG
	Former/major organisation	WMT AG (WM Therapeutics)
	Product	SNuRM™ technology (selective Nuclear Receptor Modulators)

Record changed: 2023-12-06

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Claus Kremoser

[1] Phenex Pharmaceuticals AG. (7/10/17). "Press Release: Phenex AG Announces Milestone Payment from Janssen for the Entry of RORgt Inhibitor into Phase I". Ludwigshafen....
[2] Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]